The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Alendronic Acid Market Research Report 2025
Synopsis
Alendronic acid is a bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease. It functions by preventing resorption of bone.
The global Alendronic Acid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alendronic Acid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alendronic Acid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alendronic Acid include MSD, Merck, Cobalt Laboratories (Allergan), Accel Pharma, Accord Healthcare (Intas pharmaceuticals), Angita Pharma, Teijin, Pfizer and Ipsen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alendronic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alendronic Acid.
Report Scope
The Alendronic Acid market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alendronic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alendronic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MSD
Merck
Cobalt Laboratories (Allergan)
Accel Pharma
Accord Healthcare (Intas pharmaceuticals)
Angita Pharma
Teijin
Pfizer
Ipsen
Daewoong
Zhuozhou Dongle Pharmaceutical
Yangtze Pharmaceutical Group
Wante Pharmaceutical
CSPC
Shandong Lukang Pharmaceutical Group
Hainan Quanxing Pharmaceutical
Hainan Kaijian Pharmaceutical
Guangdong Bidi Pharmaceutical
Chengdu Tiantaishan Pharmaceutical
Beijing Wansheng Pharmaceutical
Segment by Type
70 Mg Tablet
10 Mg Tablet
Segment by Application
Paget's Disease
Osteoporosis
Tumor-Associated Hypercalcemia
Osteogenesis Imperfecta
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alendronic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alendronic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Alendronic acid is a bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease. It functions by preventing resorption of bone.
The global Alendronic Acid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alendronic Acid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alendronic Acid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alendronic Acid include MSD, Merck, Cobalt Laboratories (Allergan), Accel Pharma, Accord Healthcare (Intas pharmaceuticals), Angita Pharma, Teijin, Pfizer and Ipsen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alendronic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alendronic Acid.
Report Scope
The Alendronic Acid market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alendronic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alendronic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MSD
Merck
Cobalt Laboratories (Allergan)
Accel Pharma
Accord Healthcare (Intas pharmaceuticals)
Angita Pharma
Teijin
Pfizer
Ipsen
Daewoong
Zhuozhou Dongle Pharmaceutical
Yangtze Pharmaceutical Group
Wante Pharmaceutical
CSPC
Shandong Lukang Pharmaceutical Group
Hainan Quanxing Pharmaceutical
Hainan Kaijian Pharmaceutical
Guangdong Bidi Pharmaceutical
Chengdu Tiantaishan Pharmaceutical
Beijing Wansheng Pharmaceutical
Segment by Type
70 Mg Tablet
10 Mg Tablet
Segment by Application
Paget's Disease
Osteoporosis
Tumor-Associated Hypercalcemia
Osteogenesis Imperfecta
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alendronic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alendronic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Alendronic Acid Market Overview
1.1 Product Overview and Scope of Alendronic Acid
1.2 Alendronic Acid Segment by Type
1.2.1 Global Alendronic Acid Market Value Comparison by Type (2024-2030)
1.2.2 70 Mg Tablet
1.2.3 10 Mg Tablet
1.3 Alendronic Acid Segment by Application
1.3.1 Global Alendronic Acid Market Value by Application: (2024-2030)
1.3.2 Paget's Disease
1.3.3 Osteoporosis
1.3.4 Tumor-Associated Hypercalcemia
1.3.5 Osteogenesis Imperfecta
1.3.6 Other
1.4 Global Alendronic Acid Market Size Estimates and Forecasts
1.4.1 Global Alendronic Acid Revenue 2019-2030
1.4.2 Global Alendronic Acid Sales 2019-2030
1.4.3 Global Alendronic Acid Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alendronic Acid Market Competition by Manufacturers
2.1 Global Alendronic Acid Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alendronic Acid Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alendronic Acid Average Price by Manufacturers (2019-2024)
2.4 Global Alendronic Acid Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alendronic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alendronic Acid, Product Type & Application
2.7 Alendronic Acid Market Competitive Situation and Trends
2.7.1 Alendronic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alendronic Acid Players Market Share by Revenue
2.7.3 Global Alendronic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alendronic Acid Retrospective Market Scenario by Region
3.1 Global Alendronic Acid Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alendronic Acid Global Alendronic Acid Sales by Region: 2019-2030
3.2.1 Global Alendronic Acid Sales by Region: 2019-2024
3.2.2 Global Alendronic Acid Sales by Region: 2025-2030
3.3 Global Alendronic Acid Global Alendronic Acid Revenue by Region: 2019-2030
3.3.1 Global Alendronic Acid Revenue by Region: 2019-2024
3.3.2 Global Alendronic Acid Revenue by Region: 2025-2030
3.4 North America Alendronic Acid Market Facts & Figures by Country
3.4.1 North America Alendronic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alendronic Acid Sales by Country (2019-2030)
3.4.3 North America Alendronic Acid Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alendronic Acid Market Facts & Figures by Country
3.5.1 Europe Alendronic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alendronic Acid Sales by Country (2019-2030)
3.5.3 Europe Alendronic Acid Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alendronic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific Alendronic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alendronic Acid Sales by Country (2019-2030)
3.6.3 Asia Pacific Alendronic Acid Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alendronic Acid Market Facts & Figures by Country
3.7.1 Latin America Alendronic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alendronic Acid Sales by Country (2019-2030)
3.7.3 Latin America Alendronic Acid Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alendronic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Alendronic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alendronic Acid Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alendronic Acid Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alendronic Acid Sales by Type (2019-2030)
4.1.1 Global Alendronic Acid Sales by Type (2019-2024)
4.1.2 Global Alendronic Acid Sales by Type (2025-2030)
4.1.3 Global Alendronic Acid Sales Market Share by Type (2019-2030)
4.2 Global Alendronic Acid Revenue by Type (2019-2030)
4.2.1 Global Alendronic Acid Revenue by Type (2019-2024)
4.2.2 Global Alendronic Acid Revenue by Type (2025-2030)
4.2.3 Global Alendronic Acid Revenue Market Share by Type (2019-2030)
4.3 Global Alendronic Acid Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alendronic Acid Sales by Application (2019-2030)
5.1.1 Global Alendronic Acid Sales by Application (2019-2024)
5.1.2 Global Alendronic Acid Sales by Application (2025-2030)
5.1.3 Global Alendronic Acid Sales Market Share by Application (2019-2030)
5.2 Global Alendronic Acid Revenue by Application (2019-2030)
5.2.1 Global Alendronic Acid Revenue by Application (2019-2024)
5.2.2 Global Alendronic Acid Revenue by Application (2025-2030)
5.2.3 Global Alendronic Acid Revenue Market Share by Application (2019-2030)
5.3 Global Alendronic Acid Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Description and Business Overview
6.1.3 MSD Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MSD Alendronic Acid Product Portfolio
6.1.5 MSD Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Alendronic Acid Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Cobalt Laboratories (Allergan)
6.3.1 Cobalt Laboratories (Allergan) Corporation Information
6.3.2 Cobalt Laboratories (Allergan) Description and Business Overview
6.3.3 Cobalt Laboratories (Allergan) Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cobalt Laboratories (Allergan) Alendronic Acid Product Portfolio
6.3.5 Cobalt Laboratories (Allergan) Recent Developments/Updates
6.4 Accel Pharma
6.4.1 Accel Pharma Corporation Information
6.4.2 Accel Pharma Description and Business Overview
6.4.3 Accel Pharma Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Accel Pharma Alendronic Acid Product Portfolio
6.4.5 Accel Pharma Recent Developments/Updates
6.5 Accord Healthcare (Intas pharmaceuticals)
6.5.1 Accord Healthcare (Intas pharmaceuticals) Corporation Information
6.5.2 Accord Healthcare (Intas pharmaceuticals) Description and Business Overview
6.5.3 Accord Healthcare (Intas pharmaceuticals) Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Accord Healthcare (Intas pharmaceuticals) Alendronic Acid Product Portfolio
6.5.5 Accord Healthcare (Intas pharmaceuticals) Recent Developments/Updates
6.6 Angita Pharma
6.6.1 Angita Pharma Corporation Information
6.6.2 Angita Pharma Description and Business Overview
6.6.3 Angita Pharma Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Angita Pharma Alendronic Acid Product Portfolio
6.6.5 Angita Pharma Recent Developments/Updates
6.7 Teijin
6.6.1 Teijin Corporation Information
6.6.2 Teijin Description and Business Overview
6.6.3 Teijin Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teijin Alendronic Acid Product Portfolio
6.7.5 Teijin Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Alendronic Acid Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Ipsen
6.9.1 Ipsen Corporation Information
6.9.2 Ipsen Description and Business Overview
6.9.3 Ipsen Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ipsen Alendronic Acid Product Portfolio
6.9.5 Ipsen Recent Developments/Updates
6.10 Daewoong
6.10.1 Daewoong Corporation Information
6.10.2 Daewoong Description and Business Overview
6.10.3 Daewoong Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Daewoong Alendronic Acid Product Portfolio
6.10.5 Daewoong Recent Developments/Updates
6.11 Zhuozhou Dongle Pharmaceutical
6.11.1 Zhuozhou Dongle Pharmaceutical Corporation Information
6.11.2 Zhuozhou Dongle Pharmaceutical Alendronic Acid Description and Business Overview
6.11.3 Zhuozhou Dongle Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhuozhou Dongle Pharmaceutical Alendronic Acid Product Portfolio
6.11.5 Zhuozhou Dongle Pharmaceutical Recent Developments/Updates
6.12 Yangtze Pharmaceutical Group
6.12.1 Yangtze Pharmaceutical Group Corporation Information
6.12.2 Yangtze Pharmaceutical Group Alendronic Acid Description and Business Overview
6.12.3 Yangtze Pharmaceutical Group Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yangtze Pharmaceutical Group Alendronic Acid Product Portfolio
6.12.5 Yangtze Pharmaceutical Group Recent Developments/Updates
6.13 Wante Pharmaceutical
6.13.1 Wante Pharmaceutical Corporation Information
6.13.2 Wante Pharmaceutical Alendronic Acid Description and Business Overview
6.13.3 Wante Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Wante Pharmaceutical Alendronic Acid Product Portfolio
6.13.5 Wante Pharmaceutical Recent Developments/Updates
6.14 CSPC
6.14.1 CSPC Corporation Information
6.14.2 CSPC Alendronic Acid Description and Business Overview
6.14.3 CSPC Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CSPC Alendronic Acid Product Portfolio
6.14.5 CSPC Recent Developments/Updates
6.15 Shandong Lukang Pharmaceutical Group
6.15.1 Shandong Lukang Pharmaceutical Group Corporation Information
6.15.2 Shandong Lukang Pharmaceutical Group Alendronic Acid Description and Business Overview
6.15.3 Shandong Lukang Pharmaceutical Group Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Lukang Pharmaceutical Group Alendronic Acid Product Portfolio
6.15.5 Shandong Lukang Pharmaceutical Group Recent Developments/Updates
6.16 Hainan Quanxing Pharmaceutical
6.16.1 Hainan Quanxing Pharmaceutical Corporation Information
6.16.2 Hainan Quanxing Pharmaceutical Alendronic Acid Description and Business Overview
6.16.3 Hainan Quanxing Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Hainan Quanxing Pharmaceutical Alendronic Acid Product Portfolio
6.16.5 Hainan Quanxing Pharmaceutical Recent Developments/Updates
6.17 Hainan Kaijian Pharmaceutical
6.17.1 Hainan Kaijian Pharmaceutical Corporation Information
6.17.2 Hainan Kaijian Pharmaceutical Alendronic Acid Description and Business Overview
6.17.3 Hainan Kaijian Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hainan Kaijian Pharmaceutical Alendronic Acid Product Portfolio
6.17.5 Hainan Kaijian Pharmaceutical Recent Developments/Updates
6.18 Guangdong Bidi Pharmaceutical
6.18.1 Guangdong Bidi Pharmaceutical Corporation Information
6.18.2 Guangdong Bidi Pharmaceutical Alendronic Acid Description and Business Overview
6.18.3 Guangdong Bidi Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Guangdong Bidi Pharmaceutical Alendronic Acid Product Portfolio
6.18.5 Guangdong Bidi Pharmaceutical Recent Developments/Updates
6.19 Chengdu Tiantaishan Pharmaceutical
6.19.1 Chengdu Tiantaishan Pharmaceutical Corporation Information
6.19.2 Chengdu Tiantaishan Pharmaceutical Alendronic Acid Description and Business Overview
6.19.3 Chengdu Tiantaishan Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Chengdu Tiantaishan Pharmaceutical Alendronic Acid Product Portfolio
6.19.5 Chengdu Tiantaishan Pharmaceutical Recent Developments/Updates
6.20 Beijing Wansheng Pharmaceutical
6.20.1 Beijing Wansheng Pharmaceutical Corporation Information
6.20.2 Beijing Wansheng Pharmaceutical Alendronic Acid Description and Business Overview
6.20.3 Beijing Wansheng Pharmaceutical Alendronic Acid Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Beijing Wansheng Pharmaceutical Alendronic Acid Product Portfolio
6.20.5 Beijing Wansheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alendronic Acid Industry Chain Analysis
7.2 Alendronic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alendronic Acid Production Mode & Process
7.4 Alendronic Acid Sales and Marketing
7.4.1 Alendronic Acid Sales Channels
7.4.2 Alendronic Acid Distributors
7.5 Alendronic Acid Customers
8 Alendronic Acid Market Dynamics
8.1 Alendronic Acid Industry Trends
8.2 Alendronic Acid Market Drivers
8.3 Alendronic Acid Market Challenges
8.4 Alendronic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Alendronic Acid Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Alendronic Acid Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Alendronic Acid Market Competitive Situation by Manufacturers in 2023
Table 4. Global Alendronic Acid Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Alendronic Acid Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Alendronic Acid Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Alendronic Acid Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Alendronic Acid Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Alendronic Acid, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alendronic Acid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alendronic Acid, Product Type & Application
Table 12. Global Key Manufacturers of Alendronic Acid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alendronic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alendronic Acid as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alendronic Acid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Alendronic Acid Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Alendronic Acid Sales Market Share by Region (2019-2024)
Table 19. Global Alendronic Acid Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Alendronic Acid Sales Market Share by Region (2025-2030)
Table 21. Global Alendronic Acid Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Alendronic Acid Revenue Market Share by Region (2019-2024)
Table 23. Global Alendronic Acid Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Alendronic Acid Revenue Market Share by Region (2025-2030)
Table 25. North America Alendronic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Alendronic Acid Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Alendronic Acid Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Alendronic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Alendronic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Alendronic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Alendronic Acid Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Alendronic Acid Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Alendronic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Alendronic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Alendronic Acid Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Alendronic Acid Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Alendronic Acid Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Alendronic Acid Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Alendronic Acid Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alendronic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Alendronic Acid Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Alendronic Acid Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Alendronic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alendronic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alendronic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Alendronic Acid Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Alendronic Acid Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Alendronic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Alendronic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Alendronic Acid Sales (M Pcs) by Type (2019-2024)
Table 51. Global Alendronic Acid Sales (M Pcs) by Type (2025-2030)
Table 52. Global Alendronic Acid Sales Market Share by Type (2019-2024)
Table 53. Global Alendronic Acid Sales Market Share by Type (2025-2030)
Table 54. Global Alendronic Acid Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Alendronic Acid Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Alendronic Acid Revenue Market Share by Type (2019-2024)
Table 57. Global Alendronic Acid Revenue Market Share by Type (2025-2030)
Table 58. Global Alendronic Acid Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Alendronic Acid Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Alendronic Acid Sales (M Pcs) by Application (2019-2024)
Table 61. Global Alendronic Acid Sales (M Pcs) by Application (2025-2030)
Table 62. Global Alendronic Acid Sales Market Share by Application (2019-2024)
Table 63. Global Alendronic Acid Sales Market Share by Application (2025-2030)
Table 64. Global Alendronic Acid Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Alendronic Acid Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Alendronic Acid Revenue Market Share by Application (2019-2024)
Table 67. Global Alendronic Acid Revenue Market Share by Application (2025-2030)
Table 68. Global Alendronic Acid Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Alendronic Acid Price (US$/Pcs) by Application (2025-2030)
Table 70. MSD Corporation Information
Table 71. MSD Description and Business Overview
Table 72. MSD Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. MSD Alendronic Acid Product
Table 74. MSD Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. Merck Alendronic Acid Product
Table 79. Merck Recent Developments/Updates
Table 80. Cobalt Laboratories (Allergan) Corporation Information
Table 81. Cobalt Laboratories (Allergan) Description and Business Overview
Table 82. Cobalt Laboratories (Allergan) Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. Cobalt Laboratories (Allergan) Alendronic Acid Product
Table 84. Cobalt Laboratories (Allergan) Recent Developments/Updates
Table 85. Accel Pharma Corporation Information
Table 86. Accel Pharma Description and Business Overview
Table 87. Accel Pharma Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Accel Pharma Alendronic Acid Product
Table 89. Accel Pharma Recent Developments/Updates
Table 90. Accord Healthcare (Intas pharmaceuticals) Corporation Information
Table 91. Accord Healthcare (Intas pharmaceuticals) Description and Business Overview
Table 92. Accord Healthcare (Intas pharmaceuticals) Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Accord Healthcare (Intas pharmaceuticals) Alendronic Acid Product
Table 94. Accord Healthcare (Intas pharmaceuticals) Recent Developments/Updates
Table 95. Angita Pharma Corporation Information
Table 96. Angita Pharma Description and Business Overview
Table 97. Angita Pharma Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 98. Angita Pharma Alendronic Acid Product
Table 99. Angita Pharma Recent Developments/Updates
Table 100. Teijin Corporation Information
Table 101. Teijin Description and Business Overview
Table 102. Teijin Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 103. Teijin Alendronic Acid Product
Table 104. Teijin Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 108. Pfizer Alendronic Acid Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Ipsen Corporation Information
Table 111. Ipsen Description and Business Overview
Table 112. Ipsen Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 113. Ipsen Alendronic Acid Product
Table 114. Ipsen Recent Developments/Updates
Table 115. Daewoong Corporation Information
Table 116. Daewoong Description and Business Overview
Table 117. Daewoong Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 118. Daewoong Alendronic Acid Product
Table 119. Daewoong Recent Developments/Updates
Table 120. Zhuozhou Dongle Pharmaceutical Corporation Information
Table 121. Zhuozhou Dongle Pharmaceutical Description and Business Overview
Table 122. Zhuozhou Dongle Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 123. Zhuozhou Dongle Pharmaceutical Alendronic Acid Product
Table 124. Zhuozhou Dongle Pharmaceutical Recent Developments/Updates
Table 125. Yangtze Pharmaceutical Group Corporation Information
Table 126. Yangtze Pharmaceutical Group Description and Business Overview
Table 127. Yangtze Pharmaceutical Group Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 128. Yangtze Pharmaceutical Group Alendronic Acid Product
Table 129. Yangtze Pharmaceutical Group Recent Developments/Updates
Table 130. Wante Pharmaceutical Corporation Information
Table 131. Wante Pharmaceutical Description and Business Overview
Table 132. Wante Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 133. Wante Pharmaceutical Alendronic Acid Product
Table 134. Wante Pharmaceutical Recent Developments/Updates
Table 135. CSPC Corporation Information
Table 136. CSPC Description and Business Overview
Table 137. CSPC Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 138. CSPC Alendronic Acid Product
Table 139. CSPC Recent Developments/Updates
Table 140. Shandong Lukang Pharmaceutical Group Corporation Information
Table 141. Shandong Lukang Pharmaceutical Group Description and Business Overview
Table 142. Shandong Lukang Pharmaceutical Group Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 143. Shandong Lukang Pharmaceutical Group Alendronic Acid Product
Table 144. Shandong Lukang Pharmaceutical Group Recent Developments/Updates
Table 145. Hainan Quanxing Pharmaceutical Corporation Information
Table 146. Hainan Quanxing Pharmaceutical Description and Business Overview
Table 147. Hainan Quanxing Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 148. Hainan Quanxing Pharmaceutical Alendronic Acid Product
Table 149. Hainan Quanxing Pharmaceutical Recent Developments/Updates
Table 150. Hainan Kaijian Pharmaceutical Corporation Information
Table 151. Hainan Kaijian Pharmaceutical Description and Business Overview
Table 152. Hainan Kaijian Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 153. Hainan Kaijian Pharmaceutical Alendronic Acid Product
Table 154. Hainan Kaijian Pharmaceutical Recent Developments/Updates
Table 155. Guangdong Bidi Pharmaceutical Corporation Information
Table 156. Guangdong Bidi Pharmaceutical Description and Business Overview
Table 157. Guangdong Bidi Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 158. Guangdong Bidi Pharmaceutical Alendronic Acid Product
Table 159. Guangdong Bidi Pharmaceutical Recent Developments/Updates
Table 160. Chengdu Tiantaishan Pharmaceutical Corporation Information
Table 161. Chengdu Tiantaishan Pharmaceutical Description and Business Overview
Table 162. Chengdu Tiantaishan Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 163. Chengdu Tiantaishan Pharmaceutical Alendronic Acid Product
Table 164. Chengdu Tiantaishan Pharmaceutical Recent Developments/Updates
Table 165. Beijing Wansheng Pharmaceutical Corporation Information
Table 166. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 167. Beijing Wansheng Pharmaceutical Alendronic Acid Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 168. Beijing Wansheng Pharmaceutical Alendronic Acid Product
Table 169. Beijing Wansheng Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Alendronic Acid Distributors List
Table 173. Alendronic Acid Customers List
Table 174. Alendronic Acid Market Trends
Table 175. Alendronic Acid Market Drivers
Table 176. Alendronic Acid Market Challenges
Table 177. Alendronic Acid Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alendronic Acid
Figure 2. Global Alendronic Acid Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Alendronic Acid Market Share by Type in 2023 & 2030
Figure 4. 70 Mg Tablet Product Picture
Figure 5. 10 Mg Tablet Product Picture
Figure 6. Global Alendronic Acid Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Alendronic Acid Market Share by Application in 2023 & 2030
Figure 8. Paget's Disease
Figure 9. Osteoporosis
Figure 10. Tumor-Associated Hypercalcemia
Figure 11. Osteogenesis Imperfecta
Figure 12. Other
Figure 13. Global Alendronic Acid Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Alendronic Acid Market Size (2019-2030) & (US$ Million)
Figure 15. Global Alendronic Acid Sales (2019-2030) & (M Pcs)
Figure 16. Global Alendronic Acid Average Price (US$/Pcs) & (2019-2030)
Figure 17. Alendronic Acid Report Years Considered
Figure 18. Alendronic Acid Sales Share by Manufacturers in 2023
Figure 19. Global Alendronic Acid Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Alendronic Acid Players: Market Share by Revenue in 2023
Figure 21. Alendronic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Alendronic Acid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Alendronic Acid Sales Market Share by Country (2019-2030)
Figure 24. North America Alendronic Acid Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Alendronic Acid Sales Market Share by Country (2019-2030)
Figure 28. Europe Alendronic Acid Revenue Market Share by Country (2019-2030)
Figure 29. Germany Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Alendronic Acid Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Alendronic Acid Revenue Market Share by Region (2019-2030)
Figure 36. China Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Alendronic Acid Sales Market Share by Country (2019-2030)
Figure 47. Latin America Alendronic Acid Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Alendronic Acid Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Alendronic Acid Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Alendronic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Alendronic Acid by Type (2019-2030)
Figure 57. Global Revenue Market Share of Alendronic Acid by Type (2019-2030)
Figure 58. Global Alendronic Acid Price (US$/Pcs) by Type (2019-2030)
Figure 59. Global Sales Market Share of Alendronic Acid by Application (2019-2030)
Figure 60. Global Revenue Market Share of Alendronic Acid by Application (2019-2030)
Figure 61. Global Alendronic Acid Price (US$/Pcs) by Application (2019-2030)
Figure 62. Alendronic Acid Value Chain
Figure 63. Alendronic Acid Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
